220 related articles for article (PubMed ID: 10493702)
1. Hormone replacement therapy: patterns of use studied through British general practice computerized records.
Lawrence M; Jones L; Lancaster T; Daly E; Banks E
Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
[TBL] [Abstract][Full Text] [Related]
3. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs.
Jacobs PA; Hyland ME
Maturitas; 2003 Dec; 46(4):273-81. PubMed ID: 14625124
[TBL] [Abstract][Full Text] [Related]
5. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database.
Ashworth M; Latinovic R; Charlton J; Cox K; Rowlands G; Gulliford M
J Public Health (Oxf); 2004 Sep; 26(3):268-74. PubMed ID: 15454595
[TBL] [Abstract][Full Text] [Related]
6. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
Watson J; Wise L; Green J
Eur J Clin Pharmacol; 2007 Sep; 63(9):843-9. PubMed ID: 17598097
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
8. Low use of long-term hormone replacement therapy in Denmark.
Olesen C; Steffensen FH; Sørensen HT; Nielsen GL; Olsen J; Bergman U
Br J Clin Pharmacol; 1999 Mar; 47(3):323-8. PubMed ID: 10215757
[TBL] [Abstract][Full Text] [Related]
9. Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.
Kozyrskyj A; Raymond C; Racher A
Eur J Clin Pharmacol; 2007 Jun; 63(6):597-604. PubMed ID: 17380324
[TBL] [Abstract][Full Text] [Related]
10. National use of postmenopausal hormone therapy: annual trends and response to recent evidence.
Hersh AL; Stefanick ML; Stafford RS
JAMA; 2004 Jan; 291(1):47-53. PubMed ID: 14709575
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium.
Donker GA; Spreeuwenberg P; Bartelds AI; van der Velden K; Foets M
Fam Pract; 2000 Dec; 17(6):508-13. PubMed ID: 11120723
[TBL] [Abstract][Full Text] [Related]
12. Treatment of menopausal symptoms in family medicine settings following the Women's Health Initiative findings.
Burg MA; Fraser K; Gui S; Grant K; Kosch SG; Nierenberg B; Oyama O; Pomm H; Sibille K; Spruill T; Swartz V;
J Am Board Fam Med; 2006; 19(2):122-31. PubMed ID: 16513900
[TBL] [Abstract][Full Text] [Related]
13. Prescribing of nicotine replacement therapy to adolescents in England.
Langley TE; Huang Y; Lewis S; McNeill A; Coleman T; Szatkowski L
Addiction; 2011 Aug; 106(8):1513-9. PubMed ID: 21466605
[TBL] [Abstract][Full Text] [Related]
14. The impact of the October 1995 'pill scare' on oral contraceptive use in the United Kingdom: analysis of a general practice automated database.
Martin RM; Hilton SR; Kerry SM
Fam Pract; 1997 Aug; 14(4):279-84. PubMed ID: 9283846
[TBL] [Abstract][Full Text] [Related]
15. HRT: have we changed?
Conlon O; McKinney K
Ir J Med Sci; 2006; 175(4):58-61. PubMed ID: 17312831
[TBL] [Abstract][Full Text] [Related]
16. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
18. [Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014].
Baladé Martínez L; Montero Corominas D; Macías Saint-Gerons D
Med Clin (Barc); 2016 Oct; 147(7):287-92. PubMed ID: 27423654
[TBL] [Abstract][Full Text] [Related]
19. Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database.
Bromley SE; de Vries CS; Farmer RD
BJOG; 2004 Apr; 111(4):369-76. PubMed ID: 15008775
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
